Grant opportunity

Single Source Competition for Continuation of Understanding and Targeting the Pathophysiology of Youth-Onset Type 2 Diabetes Clinical Centers (U01 Clinical Trial Not Allowed)

National Institutes of Health has posted Single Source Competition for Continuation of Understanding and Targeting the Pathophysiology of Youth-Onset Type 2 Diabetes Clinical Centers (U01 Clinical Trial Not Allowed), a health and biomedical sciences funding opportunity listed on Grants.gov under opportunity number RFA-DK-28-115. The call is relevant to Others (see text field entitled "Additional Information on Eligibility" for clarification) and should be reviewed on the official listing for final eligibility, forms, attachments and submission timing.

Pre-announcementGrantResearch fundingHealth and Biomedical SciencesUnited StatesHealthUpcoming callPre-announcement
Funder
National Institutes of Health
Forecasted close date / see official listing
Forecasted close date / see official listing
Award
Up to USD 35,000,000
Applicant
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Discipline
Health and Biomedical Sciences
Region
United States
Posted
Aug 4, 2026

Call summary

Overview

Single Source Competition for Continuation of Understanding and Targeting the Pathophysiology of Youth-Onset Type 2 Diabetes Clinical Centers (U01 Clinical Trial Not Allowed) is an official Grants.gov opportunity from National Institutes of Health. It appears under opportunity number RFA-DK-28-115 and is listed for applicants working in health and biomedical sciences.

Who can apply

Others (see text field entitled "Additional Information on Eligibility" for clarification). Applicants should confirm all additional eligibility limits, cost-sharing rules, institutional requirements and application package instructions on the official Grants.gov page.

What it supports

  • Opportunity number: RFA-DK-28-115
  • Funding category: Health
  • Funding instrument: Cooperative Agreement

Funding and duration

Up to USD 35,000,000

Forecasted close date / see official listing

Forecasted close date / see official listing

How to apply

Open the official Grants.gov listing, review the full notice of funding opportunity and application package, then submit through the Grants.gov route specified by the agency.

Call details

Source-based overview

National Institutes of Health has posted Single Source Competition for Continuation of Understanding and Targeting the Pathophysiology of Youth-Onset Type 2 Diabetes Clinical Centers (U01 Clinical Trial Not Allowed), a health and biomedical sciences funding opportunity listed on Grants.gov under opportunity number RFA-DK-28-115. The call is relevant to Others (see text field entitled "Additional Information on Eligibility" for clarification) and should be reviewed on the official listing for final eligibility, forms, attachments and submission timing.

Eligibility

Others (see text field entitled "Additional Information on Eligibility" for clarification). Applicants should confirm all additional eligibility limits, cost-sharing rules, institutional requirements and application package instructions on the official Grants.gov page.

Funding and benefits

Up to USD 35,000,000

Themes and supported activities

Opportunity number: RFA-DK-28-115

Funding category: Health

Funding instrument: Cooperative Agreement

Deadline and timeline

Forecasted close date / see official listing: Forecasted close date / see official listing.

Applicants should confirm the exact deadline time, time zone, required documents, portal steps and any institutional approvals on the official call page before submitting.

How to apply

Open the official Grants.gov listing, review the full notice of funding opportunity and application package, then submit through the Grants.gov route specified by the agency.

Before applying, check eligibility rules, budgets, attachments, page limits, partner requirements, cost-share conditions and whether the opportunity uses an expression of interest, full proposal, registration or nomination stage.